A CHF 2 Million Innosuisse Grant for Tune Insight

2025 is off to a groundbreaking start for Tune Insight, a leading EPFL spin-off specializing in privacy-preserving data collaboration solutions. The start-up secured a CHF 2 Million Innosuisse Grant to revolutionise Real-World Evidence (RWE) access for AI in pharma.

Despite growing interest in using Real-World Evidence (RWE) to fuel AI innovation in healthcare, access to patient data remains one of the biggest barriers. Tune Insight’s Federated Health Data Space is already helping leading hospitals in Europe securely collaborate on sensitive healthcare data without compromising privacy.

Thanks to a CHF 2 million Innosuisse grant, Tune Insight will now enable pharmaceutical companies to access securely shared RWE using advanced federated AI capabilities. By building AI-powered solutions that respect patient privacy, Tune Insight is driving personalized medicine while maintaining its leadership in healthcare data privacy.

In 2024, Tune Insight also started a project to improve outcomes for acutely ill and injured children in emergency care, in collaboration with Swiss and Italian hospitals—including Insel GruppeSpital in Bern and University Hospital of Padova, plus Italian SME DataRiver— and secured a €1.8 million Eurostars grant.

The project will develop and deploy a privacy-preserving federated learning platform that enables secure, cross-border research using routine electronic medical data. With over 100 hospitals and access to data from more than 2 million paediatric emergency cases annually, this initiative aims to set a new global standard for secure collaborative clinical research in paediatric emergency medicine.

 Source: LinkedIn Post
Tune Insight team: Romain Bouyé, Juan Ramón Troncoso-Pastoriza, Frederic Pont, cofounders of Tune Insight.